Legal Representation
Attorney
Jeffrey H. Greger, Esq.
USPTO Deadlines
Next Deadline
1301 days remaining
Section 8 & 9 (10-Year) Renewal Due (Based on registration date 2019-01-29)
Due Date
January 29, 2029
Grace Period Ends
July 29, 2029
Application History
30 eventsDate | Code | Type | Description |
---|---|---|---|
Jun 25, 2025 | ES71 | I | TEAS SECTION 71 RECEIVED |
Jan 29, 2024 | REM3 | E | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
Nov 21, 2023 | NREP | P | NEW REPRESENTATIVE AT IB RECEIVED |
Dec 15, 2022 | ADCH | M | CHANGE OF NAME/ADDRESS REC'D FROM IB |
Jul 26, 2019 | FINO | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
May 20, 2019 | FIMP | P | FINAL DISPOSITION PROCESSED |
May 20, 2019 | FICS | P | FINAL DISPOSITION NOTICE SENT TO IB |
Apr 29, 2019 | FICR | P | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |
Jan 29, 2019 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Nov 23, 2018 | GPNX | P | NOTIFICATION PROCESSED BY IB |
Nov 13, 2018 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Nov 13, 2018 | PUBO | A | PUBLISHED FOR OPPOSITION |
Oct 24, 2018 | OPNS | P | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB |
Oct 24, 2018 | OP2R | P | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB |
Oct 24, 2018 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Sep 26, 2018 | CNSA | O | APPROVED FOR PUB - PRINCIPAL REGISTER |
Sep 25, 2018 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Sep 25, 2018 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Sep 25, 2018 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Aug 10, 2018 | FINT | P | FINAL DECISION TRANSACTION PROCESSED BY IB |
May 19, 2018 | OPNX | P | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB |
Apr 20, 2018 | RFNT | P | REFUSAL PROCESSED BY IB |
Mar 26, 2018 | RFCS | P | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB |
Mar 26, 2018 | RFRR | P | REFUSAL PROCESSED BY MPU |
Mar 20, 2018 | RFCR | E | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW |
Mar 19, 2018 | CNRT | R | NON-FINAL ACTION WRITTEN |
Mar 14, 2018 | DOCK | D | ASSIGNED TO EXAMINER |
Feb 2, 2018 | MAFR | O | APPLICATION FILING RECEIPT MAILED |
Jan 29, 2018 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
Jan 25, 2018 | SDRC | M | SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB |
Detailed Classifications
Class 005
Pharmaceutical and veterinary products, namely, preparations for the treatment of gut dysbiosis related diseases; food supplements for humans and animals; dietary supplements for humans and animals, namely, nutritional supplements; dietary supplements for humans and animals, namely, dietetic food and beverages for medical or veterinary use; chemical preparations for medical or pharmaceutical use, namely, for the treatment of gut dysbiosis related diseases; chemical preparations for pharmaceutical or medical use, namely, microbiotherapy preparations for the repair of intestinal microbiome; bacteriological preparations for medical or veterinary use; bacterial preparations for medical or veterinary use; biological preparations for medical or veterinary use, namely for the treatment of gut dysbiosis related diseases; culture media for bacteriology; chemico-pharmaceutical preparations, namely, for the treatment of gut dysbiosis related diseases; microbiotherapy preparations for medical use for the repair of intestinal microbiome
Class 041
Education, namely classes, seminars, workshops, in the field of, microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training, namely, organization and conducting of colloquiums, conferences, congresses, seminars in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; education, namely, arranging of exhibitions for educational purposes; training, namely, arranging and conducting workshops in the field of microbiotherapy, bacteriology, gut microbiota and microbiome-based drugs; training in the field of microbiotherapy
Class 042
Evaluations and assessments in the fields of science and technology provided by engineers; scientific and technical research in the field of biomarkers, nutrition, microbiotherapy, bacteriotherapy, and therapies meant to have an effect on the gut microbiota functions; research and development of new products for others; technical project studies namely, engineering services in the nature of technical project planning for the manufacture, control and traceability of pharmaceutical products having an effect on gut microbiota or biomarkers aiming at characterizing the gut microbiota; chemical analysis; chemistry services namely, laboratory research in the field of chemistry; conducting clinical trials for others; surveying engineering work; scientific laboratory services; research in biology, bacteriology, chemistry and physics; scientific research in the field of microbiotherapy
Additional Information
Design Mark
The mark consists of a letter "M" with a stylized depiction of a feather appearing to the left.
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
005
041
042